Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol

Abstract

In subjects with low HDL cholesterol levels, CETP inhibition with torcetrapib markedly increased HDL cholesterol levels and also decreased LDL cholesterol levels, both when administered as monotherapy and when administered in combination with a statin.